This review summarizes osteoarthritis treatments from 2001-2002, emphasizing the benefits of COX-II inhibitors while raising awareness of potential cardiorenal safety concerns.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
R. W. Jubb (2002) conducted a review in Osteoarthritis. Oral and intra-articular remedies (COX-II inhibitors, glucosamine, diacerein, hyaluronan) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: